Induced dystrophin exon skipping in human muscle explants

Graham Mcclorey, Abbie Fall, H.M. Moulton, P.L. Iversen, J.E. Rasko, Monique M. Ryan, Susan Fletcher, Steve Wilton

Research output: Contribution to journalArticlepeer-review

60 Citations (Scopus)

Abstract

Antisense oligonucleotide (AO) manipulation of pre-mRNA splicing of the dystrophin gene is showing promise in overcoming Duchenne muscular dystrophy (DMD)-causing mutations. To date, this approach has been limited to studies using animal models or cultured human muscle cells, and evidence that AOs can induce exon skipping in human muscle has yet to be shown. In this study, we used different AO analogues to induce exon skipping in muscle explants derived from normal and DMD human tissue. We propose that inducing exon skipping in human muscle explants is closer to in vivo conditions than cells in monolayer cultures, and may minimize the numbers of participants in Phase I clinical studies to demonstrate proof of principle of exon skipping in human muscle. (C) 2006 Elsevier B.V. All rights reserved.
Original languageEnglish
Pages (from-to)583-590
JournalNeuromuscular Disorders
Volume16
Issue number9-10
DOIs
Publication statusPublished - 2006

Fingerprint

Dive into the research topics of 'Induced dystrophin exon skipping in human muscle explants'. Together they form a unique fingerprint.

Cite this